Published: Thursday, December 11, 2025 OKLAHOMA CITY The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes
Do we talk about this
Emerging evidence from clinical trials suggested a positive impact of GLP-1 RAs on nondiabetic obese HFpEF in terms of improving physical limitations, symptoms, and exercise function
Hands-on Botox injection training is done in a clean multi-million dollar medspa, NOT in a hotel
doi:10.1177/03635465251357593
Alternatives to Liraglutide and Semaglutide If liraglutide or semaglutide isnt working for you, consider other GLP-1 medications, next-generation combination drugs, and lifestyle-based approaches